Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
16-week, open-label, multi-center pilot study. Insulin pump naïve subjects with type 2
diabetes who are not achieving glycemic targets (screening A1C ≥ 7.0%) on an established
regimen of either: 1) ≥ 2 OAs (Cohort A), 2) basal insulin ± OAs (Cohort B), or 3)
basal-bolus insulin ± OAs (Cohort C) will initiate basal-bolus therapy with an insulin pump
using a rapid-acting insulin analog.